Lunai Bioworks Inc. (LNAI)

Last Closing Price: 0.17 (2026-10-29)

Company Description

Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $0.05M
Net Income (Most Recent Fiscal Year) $-3.56M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -6851.05%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) --
Return on Assets (Trailing 12 Months) -42.62%
Current Ratio (Most Recent Fiscal Quarter) 0.11
Quick Ratio (Most Recent Fiscal Quarter) 0.11
Debt to Common Equity (Most Recent Fiscal Quarter) --
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $-1.99
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 5.03M
Free Float 5.01M
Market Capitalization --
Average Volume (Last 20 Days) --
Beta (Past 60 Months) 0.32
Percentage Held By Insiders (Latest Annual Proxy Report) 0.50%
Percentage Held By Institutions (Latest 13F Reports) 71.41%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) --